Heiko B.
- Country
- Norway
- Department
- Pediatric department
Research Overview
Specializations
Neurodegenerative Disorders
Focused on conditions such as Alzheimer's disease, Dementia with Lewy Bodies and Mild Cognitive Impairment within a pediatric context.
- Early‑stage cognitive decline interventions
- Biomarker‑driven therapeutic assessment
- Neuroprotective drug evaluation
Research integrates cognitive testing outcomes and molecular profiling to guide treatment strategies.
Oncology & Precision Medicine
Engaged in targeted therapies for Breast cancer, KRAS G12C‑mutated non‑small cell lung cancer, small‑cell lung cancer and other rare cancers.
- Genomic‑guided drug selection
- Assessment of tumour response to targeted agents
- Implementation of precision oncology pathways
Efforts aim to align molecular alterations with clinically effective treatments.
Hematologic & Immune Disorders
Specializes in the management of Immune Thrombocytopenia and related immune‑mediated conditions.
- Evaluation of novel thrombopoietin receptor agonists
- Comparative studies of immunomodulatory therapies
- Safety profiling in refractory patient cohorts
Focus includes optimizing therapeutic response while minimizing adverse effects.
Endocrine & Metabolic Diseases
Investigates therapeutic approaches for Type 1 Diabetes and Primary adrenal insufficiency.
- Preservation of β‑cell function
- Adjunctive hormone replacement strategies
- Long‑term metabolic outcome monitoring
Studies emphasize disease‑modifying potential and quality‑of‑life impact.
Pediatric Clinical Research
Conducts investigations within the pediatric population across multiple therapeutic areas.
- Age‑appropriate safety and efficacy assessments
- Integration of pediatric dosing considerations
- Collaboration with multidisciplinary pediatric teams
Goal is to translate advances into child‑focused clinical practice.
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.